M&A Deal Summary

Baxter International Acquires Fusion Medical Technologies

On May 3, 2002, Baxter International acquired medical products company Fusion Medical Technologies for 157M USD

Acquisition Highlights
  • This is Baxter International’s 2nd transaction in the Medical Products sector.
  • This is Baxter International’s 14th largest (disclosed) transaction.
  • This is Baxter International’s 4th transaction in the United States.
  • This is Baxter International’s 2nd transaction in California.

M&A Deal Summary

Date 2002-05-03
Target Fusion Medical Technologies
Sector Medical Products
Buyer(s) Baxter International
Deal Type Add-on Acquisition
Deal Value 157M USD

Target

Fusion Medical Technologies

Fremont, California, United States
Fusion Medical Technologies, Inc. expertise in developing and commercializing proprietary products used to control bleeding during surgery.

Search 177,829 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Baxter International

Deerfield, Illinois, United States

website


Category Company
Founded 1931
Sector Medical Products
Employees60,000
Revenue 12.8B USD (2021)
DESCRIPTION
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.

Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.


DEAL STATS #
Overall 5 of 20
Sector (Medical Products) 2 of 12
Type (Add-on Acquisition) 4 of 14
State (California) 2 of 3
Country (United States) 4 of 14
Year (2002) 1 of 1
Size (of disclosed) 14 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-08-20 Cook Pharmaceutical Solutions

Bloomington, Indiana, United States

Cook Pharmaceutical Solutions provides a complete line of pharmaceutical contract manufacturing services that includes a number of sterile product dosage forms such as solutions, suspensions and freeze-dried (lyophilized) powders in a variety of delivery systems including vials and pre-filled syringes. In addition, Cook Pharmaceutical Solutions offers clinical and commercial manufacturing and packaging, a full range of quality control analytical and microbiological services, as well as validation and assistance in regulatory submissions.

Buy $219M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2002-10-01 Baxter International - Cardiovascular Businesss

Japan

Baxter International, Inc. - Cardiovascular Businesss is a manufacturer of medical products for cardio.

Sell $22M